Antiochos P.,Service De cardiologie CHUV |
Muller O.,Service De cardiologie CHUV |
Kirsch M.,Service De chirurgie cardiovasculaire CHUV |
Agostini M.,Service De cardiologie CHUV |
And 7 more authors.
Revue Medicale Suisse | Year: 2016
Mitral regurgitation (MR) is the most frequent valvular disease in industrialised countries. MR is classified as primary (mostly degenerative with valve prolapse) or secondary (mainly due to underlying ischemic heart disease resulting in deformation of the valve structure). Surgical repair represents the optimal treatment for severe primary MR, whereas the benefits of surgical correction of secondary MR are controversial. Over the past few years, transcatheter techniques have been developed to treat MR, such as the percutaneous edgetoedge procedure (MitraClip). These approaches represent a novel therapeutic choice for patients judged inoperable by the heart team . This review article aims to summarize the principles of MR assessment and discuss current therapeutic options for severe MR, taking into account the latest advances in the field.
Theumann N.,Service de Radiologie CHUV |
Richarme D.,Service de Radiologie CHUV
Schweizerische Zeitschrift fur Sportmedizin und Sporttraumatologie | Year: 2011
A precise evaluation by imaging to grade the severity of the muscle lesion is rarely performed despite its usefulness to guide the treatment in most cases. The sonographic and MRI appearances of muscle injuries help to categorize the degree of muscle injury and when the athlete can return to play. Ultrasound allows today diagnosis with similar accuracy as MRI and shows small details that could not be seen a few years before. Muscle injury may be divided into acute and chronic pathologies. This article will review the MRI and ultrasound appearance of muscle injuries from acute to chronic including healing and complications.